Be a Global Specialty
competing in the global arena
To supply patients throughout the world with our new drugs, we are first of all engaging in activities to implement our own overseas sales operations in niche areas where a large-scale marketing organization is not necessary. In South Korea and Taiwan, we have already set up wholly owned subsidiaries and have started selling products. We are also working to improve and strengthen our development and other systems, with a view to future marketing through our own sales organizations in the US and Europe.
Steps for Growing as a Global Company
ONO’s global business expansion first started with the establishment of our own sales organization in South Korea and Taiwan. Currently, we are planning to expand sales in South Korea and Taiwan. We are establishing a clinical development capability from late-stage up to applications for approval on our own in the US and Europe and we are establishing our own sales organization in the US. In the future, we aim to deliver our products to patients throughout the world through global development and the expansion of our own sales organizations.
About overseas sites
Expanding beyond Japan, we operate in the four markets: South Korea, Taiwan, UK, and US. We have established our own sales organization in South Korea and Taiwan. In the US and Europe, we are working to improve and strengthen our development and other systems, with a view to future marketing through our own sales organizations.
- The photo shows the buildings where our local subsidiaries are located.